Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A pharmacokinetic and pharmacodynamic, randomised, single dose, cross-over, partially blinded study to compare the systemic exposure and the efficacy of a fixed-dose combination of Budesonide-Salmeterol DPI capsule 75-25 μg, Budesonide-Salmeterol DPI capsule 75-12.5 μg, Budesonide-Salmeterol DPI capsule 75-6.25 μg delivered by the Axahaler versus Serevent Diskus 50 μg + Pulmicort Turbohaler 100µg co-administration in asthmatic children

Next Previous
X
Search
Trial Profile

A pharmacokinetic and pharmacodynamic, randomised, single dose, cross-over, partially blinded study to compare the systemic exposure and the efficacy of a fixed-dose combination of Budesonide-Salmeterol DPI capsule 75-25 μg, Budesonide-Salmeterol DPI capsule 75-12.5 μg, Budesonide-Salmeterol DPI capsule 75-6.25 μg delivered by the Axahaler versus Serevent Diskus 50 μg + Pulmicort Turbohaler 100µg co-administration in asthmatic children

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 27 Dec 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Budesonide/salmeterol (Primary) ; Budesonide; Salmeterol
  • Indications Asthma
  • Focus Pharmacokinetics
  • Sponsors Laboratoires SMB

    • Most Recent Events

    • 21 Dec 2018 Status changed from recruiting to completed.
    • 16 Dec 2017 Status changed from planning to recruiting.
    • 06 Dec 2017 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top